IRIS
DE MURO, Pierina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.129
AS - Asia 1.996
SA - Sud America 1.255
EU - Europa 1.247
AF - Africa 72
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
Totale 7.715
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.063
BR - Brasile 1.135
CN - Cina 745
SG - Singapore 739
UA - Ucraina 524
HK - Hong Kong 214
DE - Germania 182
IT - Italia 124
SE - Svezia 100
FI - Finlandia 87
FR - Francia 68
GB - Regno Unito 67
TR - Turchia 55
VN - Vietnam 48
AR - Argentina 47
CA - Canada 29
IQ - Iraq 27
ZA - Sudafrica 26
BE - Belgio 24
MX - Messico 22
PK - Pakistan 22
BD - Bangladesh 21
VE - Venezuela 21
KR - Corea 20
EC - Ecuador 19
IN - India 19
MA - Marocco 17
RU - Federazione Russa 17
JP - Giappone 16
PL - Polonia 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 8
ES - Italia 8
EU - Europa 8
PE - Perù 8
CL - Cile 7
ID - Indonesia 7
PY - Paraguay 7
AU - Australia 6
CO - Colombia 6
KE - Kenya 6
NP - Nepal 6
TN - Tunisia 6
DZ - Algeria 5
IL - Israele 5
JO - Giordania 5
NL - Olanda 5
GR - Grecia 4
AT - Austria 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GE - Georgia 3
KZ - Kazakistan 3
LB - Libano 3
UY - Uruguay 3
AL - Albania 2
BO - Bolivia 2
CG - Congo 2
CH - Svizzera 2
CI - Costa d'Avorio 2
GT - Guatemala 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
LT - Lituania 2
OM - Oman 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
GA - Gabon 1
HN - Honduras 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MR - Mauritania 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.715
Salva come PNG Salva come JPEG
Città #
Dallas 970
Chandler 435
Singapore 402
Jacksonville 316
Hong Kong 214
Princeton 158
Nanjing 147
Beijing 135
Dearborn 104
São Paulo 87
Ann Arbor 83
New York 81
Ashburn 77
Wilmington 72
Nanchang 65
Sassari 59
Shanghai 45
Boardman 43
Shenyang 43
Hebei 39
Rio de Janeiro 39
Woodbridge 31
Changsha 30
Belo Horizonte 29
Los Angeles 29
Tianjin 28
Ningbo 26
Brussels 24
Izmir 24
Campinas 22
Ho Chi Minh City 22
Mountain View 22
Hangzhou 21
Santa Clara 21
Curitiba 20
Seoul 20
Buffalo 19
Jinan 19
Johannesburg 19
Zhengzhou 18
Jiaxing 17
Tokyo 15
Baghdad 14
Kunming 14
Andover 13
Brasília 13
Norwalk 13
San Francisco 13
Toronto 13
Warsaw 13
Goiânia 12
Tashkent 12
Columbus 11
London 11
Council Bluffs 10
Guangzhou 10
Guarulhos 10
Porto Alegre 10
Ribeirão Preto 10
Sorocaba 10
The Dalles 10
Betim 9
Brooklyn 9
Casablanca 9
Helsinki 9
Manaus 8
Stockholm 8
São José dos Campos 8
Campo Grande 7
Caxias do Sul 7
Fortaleza 7
Orem 7
Osasco 7
Phoenix 7
Quito 7
Santo André 7
Villiers-sur-marne 7
Americana 6
Auburn Hills 6
Blumenau 6
Boston 6
Carapicuíba 6
Chennai 6
Denver 6
Dhaka 6
Florianópolis 6
Franca 6
Istanbul 6
Itajaí 6
Lanzhou 6
Lima 6
Montreal 6
Nairobi 6
Recife 6
Taizhou 6
Uberlândia 6
Amman 5
Atlanta 5
Bauru 5
Belém 5
Totale 4.569
Salva come PNG Salva come JPEG
Nome #
Albumin-bound low molecular weight thiols analysis in plasma and carotid plaques by CE 179
Apolipoprotein Profiles in Atherosclerotic Disease 160
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 149
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 139
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 137
Apolipoprotein Profiles in Atherosclerotic Disease 136
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 135
A longitudinal evaluation of urinary glycosaminoglycan excretion in normoalbuminuric type 1 diabetic patients 133
Polymorphism of foetal haemoglobin in the sardinian Beta+-Thalassaemia. 124
DNA polymorphisms in north-Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with B°-thalassemia 123
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 121
Buoyant density of Lp(a) subclasses in hypercholesterolemia 120
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 120
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 119
Dna polymorphisms in north sardinian newborns and their linkage with abnormal globin gene arrangiements and with beta°-thalassemia 118
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 118
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 116
Quali-quantitative analysis of urinary glycosaminoglycans for monitoring glomerular inflammatory activity 116
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 115
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 115
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 113
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 112
Polymorphism of foetal haemoglobin in the Sardinian B+-thalassemia 110
Characterization of glycosaminoglycans in human plasma from patients receiving haemodyalisis and their interaction with human LDL 109
Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus 109
Sulphated polysaccharide content and localization in some marine sponge species. 108
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 107
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 107
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 107
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 103
Characterization of a protein-glycosaminoglycan complex in urine from healthy subjects 102
Blood and urine glycosaminoglycan variations during different hypocholesterolemic therapies in type 2 diabetic patients 101
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 100
Urinary glycosaminoglycan composition in chronic glomerulonephritis 98
Hb G-Philadelphia, or [alpha68(E17)AsnLys], in North Sardinia: detection by isoelectric focusing and HPLC of tryptic peptides 97
Glycosamynoglycan diversity in sponge extracellular matrix 97
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 97
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 96
Ruolo dei proteoglicani nella medicina della riproduzione 94
Structural and functional modifications of human aorta proteoglycans in atherosclerosis 92
Urine bikunin as a marker of renal impairment in Fabry's disease 92
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 91
Haematological and biosynthetic features of beta°-thalassemia with an associated alpha-thalassemia heterozygosity in Sardinia 91
GAG and protein composition of GAG-protein complexes from normal human plasma 90
Urinary glycosaminoglycans in patients with systemic lupus erythematosus 89
Urine Bikunin Quantitation and Structural Characterization in Type I and Type II Diabetes Patients 89
Atherosclerotic modifications of human proteoglycans 88
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 88
Role of the small proteoglycan bikunin in human reproduction 86
Plasma GAG-protein complexes modify chemical and physical properties of human LDL 86
Urinary excretion of GAGs during hypocholesterolemic therapy 86
Evidences that atherosclerotic lesion involves modifications of arterial wall proteoglycans, affecting their interactions with LDL 85
Preliminary investigations of LDL interactions with proteoglycans extracted from human aortic walls with different atherosclerotic lesions 84
Ldl interaction with proteoglycans isolated from human aortas with different atherosclerotic involvement 84
DNA polymorphisms in North Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with betao-thalassemia. 83
Iloprost therapy acutely decreases oxidative stress in patients affected by systemic sclerosis 82
The gamma globin chain heterogeneity of the Sardinian newborn baby. Hemoglobin, 10:519-528, 1986. 80
Proteoglicani e diabete gestazionale: dati preliminari 79
Urinary transforming growth factor-beta 1 in various types of nephropathy 78
Urinary transaforming growth factor beta 1 in various types of nephropathy 77
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 77
Diversità molecolare negli invertebrati marini: screening dei glicosaminoglicani in spugne del Mediterraneo occidentale 77
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-ϒ (MIG) 76
Urinary glycosaminoglycansin patients with systemic lupus erytematosus 74
Post-translational modifications of proteoglycans during the development of atherosclerotic lesion 74
Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles 74
Glycosaminoglycan biodiversity in W-Mediterranean marine sponges. 73
The gamma globin chain heterogeneity of the Sardinian newborn baby 72
Modification of low density lipoprotein induced by the interaction with standard GAGs 71
Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium 70
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 69
Hematological and biosynthetic features of betao-thalassemia with an associated beta-thalassemia heterozygosity in Sardinia. 68
Glycosaminoglycans and fabry’s disease 68
Proteomic analysis of plasma-purified VLDL, LDL and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 68
Investigations on PGs extracted from human aorta of different age and with different atherosclerotic lesions 65
Modifications of low density lipoprotein induced by the interaction with human plasma glycosaminoglycan-protein complexes 65
Glycosaminoglycan diversity in sponge extracellular matrix 64
Plasma Levels of C-Reactive Protein, Leptin and Glycosaminoglycans During Spontaneous Menstrual Cycle: Differences Between Ovulatory and Anovulatory Cycles 64
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 61
Human LDL binding to plasma high charge glycosaminoglycan-protein complexes 60
Totale 7.750
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.304
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021329 0 0 0 0 0 19 85 4 95 98 16 12
2021/2022396 62 3 0 11 6 2 24 26 46 25 39 152
2022/2023802 84 54 14 149 82 141 0 93 130 9 28 18
2023/2024227 45 19 7 4 48 50 1 11 0 1 23 18
2024/20252.307 18 17 128 30 110 48 192 368 827 403 108 58
2025/20261.936 119 774 351 376 264 52 0 0 0 0 0 0
Totale 7.750